drugset / Trial / NCT01252186
A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
RandomizedParallel-groupOpen-labelBasic science
Summary
This study is being conducted to evaluate the impact of a 91-day extended cycle oral contraceptive compared to two 28-day oral contraceptive regimens on hemostatic parameters in healthy women.
Timeline
- Start
- 2010-11
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | 28-day Desogestrel Oral Contraceptive | Unknown | 30 ug | Oral |
| Comparator | 28-day Levonorgestrel Oral Contraceptive | Unknown | 30 ug | Oral |
| Comparator | Desogestrel | Small molecule | 150 ug | Oral |
| Comparator | Levonorgestrel | Small molecule | 150 ug | Oral |
| Subject | ethinyl estradiol | Small molecule | 30 ug | Oral |